Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Organoids

Assessing the toxicity of bispecific antibodies

Nature Biomedical Engineering volume 8, pages 339–340 (2024)Cite this article

Subjects

The on-target off-tumour toxicities of T-cell-engaging bispecific antibodies in patients can be captured in intestinal organoids derived from the patients’ biopsied tissue and supplemented with immune cells.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Organoid models generated from healthy and malignant intestinal tissues and co-cultured with allogeneic T cells for the study of the on-target off-tumour toxicities of TCBs.

References

  1. Hay, M., Thomas, D. W., Craighead, J. L., Economides, C. & Rosenthal, J. Nat Biotechnol. 32, 40–51 (2014).

    Article  CAS  PubMed  Google Scholar 

  2. Clevers, H. Cell 165, 1586–1597 (2016).

    Article  CAS  PubMed  Google Scholar 

  3. Schnalzger, T. E. et al. EMBO J. 38, e100928 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gonzalez-Exposito, R. et al. J. Immunother. Cancer 7, 101 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Harter, M. F. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01156-5 (2023).

    Article  PubMed  Google Scholar 

  6. Xu, H. et al. Exp. Hematol. Oncol. 7, 30 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Votanopoulos, K. I. et al. Ann. Surg. Oncol. 27, 1956–1967 (2020).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Tumour Biology, Barts Cancer Institute, Charterhouse Square, London, UK

    Marta Buzzetti & Marco Gerlinger

Authors
  1. Marta Buzzetti
    View author publications

    Search author on:PubMed Google Scholar

  2. Marco Gerlinger
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Marco Gerlinger.

Ethics declarations

Competing interests

M.G. receives institutional research funding from Bristol Myers Squibb, Merck KG and Roche, speaker fees from Bristol Myers Squibb and Merck KG, and expert advisory fees from Merck Sharp and Dohme and Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buzzetti, M., Gerlinger, M. Assessing the toxicity of bispecific antibodies. Nat. Biomed. Eng 8, 339–340 (2024). https://doi.org/10.1038/s41551-023-01163-6

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41551-023-01163-6

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research